Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-015349

President and CEO acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Touchon Pascal President and CEO 2020-03-01 Grant or award +150,000 280,174 D
Derivatives
Touchon Pascal President and CEO 2020-03-01 Grant or award · Employee Stock Option (Right to Buy) +242,000 242,000 D
Loading xslF345X03/doc4.xml…